Logo
SearchSearch
Languages
Language
LoginSign up
Invest in ProQR Therapeutics NV
Today
Create an eToro account to buy PRQR stock on a secure, user-friendly, multi-asset trading platform.
Buy ProQR Therapeutics NV
Buy ProQR Therapeutics NV
ProQR Therapeutics NV PRQR
Stocks-PRQR-ProQR Therapeutics NV

ProQR Therapeutics NV PRQR

$2.56-0.02(-0.78%)(1D)

PRQR Stock Price Chart

‎15.45‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The ProQR Therapeutics NV share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The ProQR Therapeutics NV share price today is $2.56, reflecting a ‎-0.78‎% change over the last 24 hours and ‎5.39‎% over the past week. The current market capitalization of PRQR is 264.2M with an average volume in the last three months of 412576.37. The stock has a P/E ratio of -7.96 and a dividend yield of 0%. With the stock’s beta sitting at 0.76
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$264.2M

Day’s Range
i
Shows the high and low prices of the day.
1.98 - 2.62

52W Range
i
Shows the high and low prices of the last year.
1.08 - 4.58

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
412576.37

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-7.96

Revenue
i
The total income generated by this company’s goods and services last year.
$19.37M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$2.56

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.32

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.76

What Is ProQR Therapeutics NV?
ProQR Therapeutics is a healthcare firm focussing on the creation of RNA-based therapeutics. It was founded in Leiden, the Netherlands in 2012 and works internationally to combat genetic diseases. It is now traded on the NASDAQ GM under the ticker PRQR. Find out more about PRQR share price news here.

How can I buy ProQR Therapeutics NV stocks?

To purchase ProQR Therapeutics NV:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the ProQR Therapeutics NV (PRQR) page and place an order to buy ProQR Therapeutics NV.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy ProQR Therapeutics NV
Invest in ProQR Therapeutics NV
Today
Create an eToro account to buy PRQR stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of PRQR is $2.56.
The average price target for ProQR Therapeutics NV is $2.56. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for ProQR Therapeutics NV based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of ProQR Therapeutics NV is $264.2M
Scroll to top